Gardasil 9 00006-4121
Generic: Human Papillomavirus 9-Valent Vaccine, Recombinant
Product NDC
00006-4121- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- December 10, 2014
- Listing Expires
- December 31, 2026
- Application
- BLA125508
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Papillomavirus Type 11 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 16 L1 Capsid Protein Antigen | 60 ug/.5mL |
| Human Papillomavirus Type 18 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 31 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 33 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 45 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 52 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 58 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 6 L1 Capsid Protein Antigen | 30 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(1)
10 SYRINGE, GLASS in 1 CARTON (0006-4121-02) / .5 mL in 1 SYRINGE, GLASS (0006-4121-01)
External Resources